EUVIMEDEUVIMED entdecken
Crossref

Lineage-specific steroidomic signatures in pituitary neuroendocrine tumors: pregnenolone enrichment in SF-1 lineage and associations with tumor behavior

Ebubekir Akpinar, Aslihan Pekmezci, Suat Demir, Buruc Erkan, Ebru Turgal, Erdem Altan, Burak Kocak, Huseyin Karatay, Fatih Mert Dogukan, Esra Hatipoglu iD

Endocrine-Related Cancer · 2026

DOI: 10.1530/erc-26-0154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Ebubekir Akpinar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Health Sciences, Basaksehir Cam and Sakura City Hospital , Istanbul, Turkey. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Neuroendocrine Tumors, Pregnenolone, Steroidogenic Factor 1. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pituitary neuroendocrine tumors (PitNETs) exhibit diverse biological behaviors, yet the metabolic determinants underlying lineage-specific characteristics remain poorly understood. This study characterized intratumoral steroid metabolite profiles in relation to transcription factor (TF)-defined lineages and radiological tumor features in 69 PitNET specimens obtained during transsphenoidal surgery between 2021 and 2023. Tumors were classified according to the WHO 2022 TF-based criteria (SF-1, PIT-1, and TPIT). Tissue concentrations of 14 steroid metabolites were quantified via liquid chromatography–tandem mass spectrometry, with associations evaluated using multivariable regression and partial least squares discriminant analysis (PLS-DA). Gonadotroph tumors (n = 34) exhibited marked pregnenolone (PREG) elevation compared with other lineages (median: 104.6 vs 1.2 ng/g, P < 0.001, ε2 = 0.38). Corticotroph tumors (n = 9) showed enrichment of glucocorticoid metabolites, particularly 11-deoxycortisol (adjusted P = 0.002, ε2 = 0.30), while PIT-1 tumors (n = 23) displayed intermediate levels. PLS-DA corroborated these patterns, with 11-deoxycortisol and pregnenolone emerging as the primary discriminators (68% total variance). Multivariable analysis confirmed SF-1 lineage to be independently associated with PREG levels after adjusting for clinical and radiological covariates (adjusted R2 = 0.56, P < 0.001). Inverse associations were observed between deoxycorticosterone/11-deoxycortisol and tumor expansion (r = −0.7 and r = −0.4, both P < 0.001), and PREG correlated with cavernous sinus invasion within gonadotroph tumors (P = 0.03). During follow-up (median: 32–38 months), steroid profiles showed no association with clinical outcomes. TF-defined PitNET lineages exhibit distinct intratumoral steroid profiles reflecting intrinsic metabolic properties of lineage-specific cell populations, revealing a novel metabolic dimension to PitNET biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsNeuroendocrine TumorsPregnenoloneSteroidogenic Factor 1HumansFemaleMaleMiddle AgedAdultAged

Stichwörter der Autor:innen

PitNETSF-1 (steroidogenic factor 1)TPIT (T-box transcription factor)cell lineageintratumoral steroidspregnenolone

Substanzen

PregnenoloneSteroidogenic Factor 1

Autor:innen und Institutionen

  • Department of Neurosurgery, University of Health Sciences, Basaksehir Cam and Sakura City Hospital , Istanbul, Turkey.
  • University of Health Sciences, Pituitary Disorders Application and Research Center (HATMER) , Basaksehir, Turkey.
  • Division of Endocrinology, Department of Internal Medicine, University of Health Sciences, Basaksehir Cam and Sakura City Hospital , Istanbul, Turkey.
  • Strathclyde Institute of Pharmacy & Biomedical Sciences , Glasgow, United Kingdom.
  • Department of Radiology, Basaksehir Cam and Sakura City Hospital , Istanbul, Turkey.
  • Department of Pathology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital , Istanbul, Turkey.

ORCID-Profile: Esra Hatipoglu

Zitieren

APA

Akpinar, E., Pekmezci, A., Demir, S., Erkan, B., Turgal, E., Altan, E., Kocak, B., Karatay, H., Dogukan, F. M., & Hatipoglu, E. (2026). Lineage-specific steroidomic signatures in pituitary neuroendocrine tumors: pregnenolone enrichment in SF-1 lineage and associations with tumor behavior. Endocrine-Related Cancer. https://doi.org/10.1530/erc-26-0154

Vancouver

Akpinar E, Pekmezci A, Demir S, Erkan B, Turgal E, Altan E, et al. Lineage-specific steroidomic signatures in pituitary neuroendocrine tumors: pregnenolone enrichment in SF-1 lineage and associations with tumor behavior. Endocrine-Related Cancer. 2026. doi:10.1530/erc-26-0154

BibTeX
@article{Akpinar2026,
  author = {Akpinar, Ebubekir and Pekmezci, Aslihan and Demir, Suat and Erkan, Buruc and Turgal, Ebru and Altan, Erdem and Kocak, Burak and Karatay, Huseyin and Dogukan, Fatih Mert and Hatipoglu, Esra},
  title = {Lineage-specific steroidomic signatures in pituitary neuroendocrine tumors: pregnenolone enrichment in SF-1 lineage and associations with tumor behavior},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  doi = {10.1530/erc-26-0154}
}
Kostenlos starten →